Nvidia Stock Rises. It Hit This Milestone.
Barrons· 2025-10-20 11:17
Nvidia could be shielded from tariffs due to its investment in American manufacturing ...
Alpha Modus CEO: “Welcome the Shorts — We’ll Prove Our Commercial Traction”
Globenewswire· 2025-10-20 11:17
Core Viewpoint - The recent surge in short interest in Alpha Modus Holdings, Inc. shares is seen as a positive indicator of market attention rather than a concern for the company [2][3]. Company Overview - Alpha Modus Holdings, Inc. develops, licenses, and enforces AI-driven retail technologies aimed at enhancing in-store digital experiences, planogram intelligence, targeted promotions, and retail analytics [6]. - The company's patent portfolio encompasses foundational methods for AI applications in retail, positioning it to capture a significant share of the growing AI-in-retail market [6]. Short Interest Dynamics - The increase in short positions is attributed to Alpha Modus being a new public company that is just beginning to scale its commercial operations, with revenue generation already underway [3]. - The company has a small public float, which can amplify volatility and create potential short-covering pressure with significant announcements [4]. Intellectual Property and Strategy - Alpha Modus's intellectual property spans the entire spectrum of AI in retail, with a coordinated enforcement and commercialization program that covers numerous patents across the industry [5]. - The company is focused on expanding its partner network, executing new licensing agreements, and announcing additional revenue-generating activities, which may challenge those betting against it [5].
Summit Therapeutics Posts Wider Loss In Q3
RTTNews· 2025-10-20 11:15
Summit Therapeutics Inc. (SMMT) posted a GAAP net loss in the third quarter of $231.8 million or $0.31 per share, compared to a loss of $56.3 million or $0.08 per share, a year ago. Non-GAAP net loss in the third quarter was $101.0 million or $0.13 per compared to a loss of $36.9 million or $0.05 per share, prior year.Summit also announced that, based on the results of the HARMONi clinical trial, it plans to submit a Biologics License Application in order to seek approval for ivonescimab plus chemotherapy. ...
Raymond James Not Indexed To Big Deal Deltas
Seeking Alpha· 2025-10-20 11:15
If you thought our angle on this company was interesting, you may want to check out our idea room, The Value Lab . We focus on long-only value ideas of interest to us, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value investor serious about protecting your wealth, our gang could help broaden your horizons and give some ins ...
Mowi gets EC approval for controlling stake in salmon peer Nova Sea
Yahoo Finance· 2025-10-20 11:15
Norwegian seafood major Mowi has said its bid for an increased stake in Nova Sea has been approved by the European Commission. Clearance was given on Friday (17 October) for Mowi to raise its interest in its Norway-based salmon farming and processing peer to 95% from 49%, an acquisition announced in January. Mowi is taking the additional shares from Nova Sea investor Vigner Olaisen for Nkr7.4bn ($736.2m today). The European Commission (EC) only became aware of the deal in September, when the regulatory ...
STLLR Gold Appoints a Seasoned Finance Executive to its Board
Newsfile· 2025-10-20 11:15
STLLR Gold Appoints a Seasoned Finance Executive to its BoardOctober 20, 2025 7:15 AM EDT | Source: STLLR Gold Inc.Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - STLLR Gold Inc. (TSX: STLR) (OTCQX: STLRF) (FSE: O9D) ("STLLR" or the "Company") is pleased to announce the appointment of Mandy Wong, CPA, CA, to its Board of Directors, effective immediately.Ms. Wong is a seasoned finance executive with over 15 years of leadership experience in the global gold mining industry. She currently ...
Mogotes Metals Announces Acquisition of 100% of Argentina Land Package and Grant of Options
Newsfile· 2025-10-20 11:15
Mogotes Metals Announces Acquisition of 100% of Argentina Land Package and Grant of OptionsOctober 20, 2025 7:15 AM EDT | Source: Mogotes Metals Inc.Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Mogotes Metals Inc. (TSXV: MOG) (FSE: OY4) (OTCQB: MOGMF) ("Mogotes", or the "Company") is pleased to announce that it has issued an aggregate of 4,687,500 common shares in the capital of the Company (each, a "Common Share") to Golden Arrow Resources Corp. ("Golden Arrow") to complete its acq ...
Jiuzi Holdings, Inc Enters Strategic Partnership with BitFi to Advance Bitcoin-Centric Finance
Prnewswire· 2025-10-20 11:15
Accessibility StatementSkip Navigation HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the "Company") today formally announced it has signed a Strategic Cooperation Agreement with leading Bitcoinfintech platform BitFi. Specializing in multi-chain staking and yield generation for BTC, BitFi delivers targeted, auditable Bitcoin income solutions for institutions and high-net-worth investors through integrated asset wrapping (wrapped BTC), cross-chain arbitrage, and hybrid str ...
Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion
Seeking Alpha· 2025-10-20 11:15
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...
US FDA approves Glaukos' new eye therapy
Reuters· 2025-10-20 11:10
The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp , giving patients a less painful and more convenient option to treat a progressive condition that can severely af... ...